Evidence map›Paper›PMID 22121370›Full record

ArticleInternational journal of otolaryngology2011

Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection.

M E Huth, A J Ricci, A G Cheng

Abstract read
In one paragraph

Article in International journal of otolaryngology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 206 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
206citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

206 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Intratympanic gentamicin for Ménière's disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Antibiotic regimens for early-onset neonatal sepsis.The Cochrane database of systematic reviews · 2021
    Pooled it
  4. Antibiotic regimens for late-onset neonatal sepsis.The Cochrane database of systematic reviews · 2021
    Pooled it
  5. Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2018
    Pooled it
  6. Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2020
    Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Drug Discovery Targeting Nicotinic Acetylcholine Receptors for Hearing Loss.International journal of molecular sciences · 2026
    Review
  12. M.827A>G Variant in MT-RNR1 and Its Association With Hearing Loss: A Study in the Taiwanese Adult Population.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Hair cell apoptosis and deafness inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article

146 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M E HuthDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, 801 Welch Road, Stanford, CA 94305-5739, USA.
A J Ricci
A G Cheng

Funding

Tonotopic variations in mechano-electric transductionR01DC003896 · NIDCD · STANFORD UNIVERSITY · PI RICCI, ANTHONY J · 1999 to 2022
$11.1M
Regulation of Inner Ear Stem CellsK08DC011043 · NIDCD · STANFORD UNIVERSITY · PI CHENG, ALAN GI-LUN · 2010 to 2014
$1.1M
Developing Non-Ototoxic AminoglycosidesR21DC012183 · NIDCD · STANFORD UNIVERSITY · PI RICCI, ANTHONY J · 2011 to 2012
$439k
NIDCD NIH HHS K08 DC011043NIDCD NIH HHS R01 DC003896NIDCD NIH HHS R21 DC012183
6 · The paper itself

Abstract

Aminoglycosides are commonly prescribed antibiotics with deleterious side effects to the inner ear. Due to their popular application as a result of their potent antimicrobial activities, many efforts have been undertaken to prevent aminoglycoside ototoxicity. Over the years, understanding of the antimicrobial as well as ototoxic mechanisms of aminoglycosides has increased. These mechanisms are reviewed in regard to established and potential future targets of hair cell protection.

Identifiers

PMID22121370
PMCPMC3202092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.